26
Views
1
CrossRef citations to date
0
Altmetric
Review

Successful vaccination for Lyme disease: a novel mechanism?

Pages 783-793 | Published online: 23 Feb 2005

Bibliography

  • BURGDORFER W, BARBOUR AG, HAYES SF et al: Lyme disease-a tick-borne spirochetosis? Science (1982) 216:1317–1319.
  • •First description of Borrelia burgdorferi as the etiologic agent of Lyme disease.
  • YOUND J: Underreporting of Lyme disease. N Engl. J. Med. (1998) 50:381–400.
  • FRASER CM, CASJENS S, HUANG WM etal.: Genomic sequence of a Lyme disease spirochaete. Nature (1997) 390:580–586.
  • •Genomic sequence of Borrelia burgdorferi
  • CASJENS S, PALMER N, VAN VUGT R et al.: A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mal Microbial (2000) 35:490–516.
  • ZHANG J, HARDHAM J, BARBOUR A, NORRIS S: Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 89:275–285.
  • •Description of the antigenic variation system in Btu-fella burgdorferi.
  • CASJENS S, VAN VUGT K, TILLY K,ROSA P, STEVENSON B: Homology throughout the multiple 32-kilobase circular plasmids present in Lyme disease spirochetes. j. Bacterial (1997) 179:217–227.
  • ZUCKERT W, MEYER J: Circular and linear plasmids of Lyme disease spirochetes have extensive homology: characterization of a repeated DNA element. j. Bacterial (1996) 178:2287-2298. Expert Op/n. Biol. Ther. (2001) 1(5)
  • MARCONI RT, SUNG SY, HUGHES CA, CARLYON JA: Molecular and evolutionary analyses of a variable series of genes in Borrelia burgdorlarithat are related to ospE and ospF, constitute a gene family and share a common upstream homology box. Bacterial (1996) 178:5615–5626.
  • EL-HAGE N, BABB K, CARROLL JA et al.: Surface exposure and protease insensitivity of Borrelia burgdorlari Erp (OspEF-related) lipoproteins. Microbiology (2001) 147:821–830.
  • STEVENSON B, BONO JL, SCHWAN TG, ROSA P: Borrelia burgdorlari erp proteins are immunogenic in mammals infected by tick bite and their synthesis is inducible in cultured bacteria. Infect. Immun. (1998) 66:2648–2654.
  • FIKRIG E, CHEN M, BARTHOLD SW et al.: Borrelia burgdorlari erpT expression in the arthropod vector and murine host. Mal Microbial (1999) 31:281–290.
  • EL HAGE N, LIETO LD, STEVENSON B: Stability of erp loci during Borrelia burgdorlari infection: recombination is not required for chronic infection of immunocompetent mice. Infect. bran= (1999) 67:3146–3150.
  • RAMAMOORTHY R, POVINELLI L, PHILIPP MT: Molecular characterization, genomic arrangement and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorlari Infect. bran= (1996) 64:1259–1264.
  • ARON L, TOTH C, GODFREY HP, CABELLO FC: Identification and mapping of a chromosomal gene cluster of Borrelia burgdorlari containing genes expressed in vivo. FEMS Microbial Lett. (1996) 145:309–314.
  • DOBRIKOVA EY, BUGRYSHEVA J, CABELLO FC: Two independent transcriptional units control the complex and simultaneous expression of the bmp paralogous chromosomal gene family in Borrelia burgdorlari Mal. Microbial (2001) 39:370–378.
  • LAWRENZ MB, HARDHAM JM, OWENS RT etal.: Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorlari j Glitz Microbial (1999) 37:3997–4004.
  • LIANG FT, PHILIPP MT: Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorlari Infect. Immun. (1999) 67:6702–6706.
  • ZHANG JR, NORRIS SJ: Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect. Immun. (1998) 66:3689–3697.
  • OHNISHI J, PIESMAN J, DE SILVA AM: Antigenic and genetic heterogeneity of Borrelia burgdorlari populations transmitted by ticks. Proc. Natl. Acad. Sd. USA (2001) 98:670–675.
  • STRLE F, CHENG Y, CIMPERMAN J et al.: Persistence of Borrelia burgdorlari sensu Iota in resolved erythema migrans lesions. Chit. Infect. Dis. (1995) 21:380–389.
  • HAUPL T, HAHN G, RITTIG M et al.: Persistence of Borrelia burgdorkri in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum. (1993) 36:1621–1626.
  • HOFMEISTER EK, GLASS GE, CHILDS JE, PERSING DH: Population dynamics of a naturally occurring heterogeneous mixture of Borrelia burgdorlariclones. Infect Immun. (1999) 67:5709–5716.
  • BARTHOLD SW: Specificity of infection-induced immunity among Borrelia burgdorlarisensu lato species. Infect Immun. (1999) 67:36–42.
  • SHANG ES, CHAMPION CI, WU XY et al.: Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorkri following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A. Infect. Immun. (2000) 68:4189–4199.
  • SKARE JT, SHANG ES, FOLEY DM et al.: Virulent strain associated outer membrane proteins of Borrelia burgdorlari. Chit. Invest. (1995) 96:2380–2392.
  • CASSATT DR, PATEL NK, ULBRANDT ND, HANSON MS: DbpA, but not OspA, is expressed by Borrelia burgdorkri during spirochetemia and is a target for protective antibodies. Infect. Immun. (1998) 66:5379–5387.
  • CHAMPION CI, BLANCO DR, SKARE JT et al: A 9.0-kilobase-pair circular plasmid of Borrelia burgdorlari encodes an exported protein: evidence for expression only during infection. Infect. Immun. (1994) 62: 2653–2661.
  • DAS S, BARTHOLD SW, GILES SS et al:Temporal pattern of Borrelia burgdorlarip21 expression in ticks and the mammalian host. Chit. Invest. (1997) 99:987–995.
  • FIKRIG E, BARTHOLD SW, SUN Wet al.: Borrelia burgdorlari P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity (1997) 6:531–539.
  • SCHWAN TG, PIESMAN J, GOLDE WT, DOLAN MC, ROSA PA: Induction of an outer surface protein on Borrelia burgdorkri during tick feeding. Proc. Nati Acad. Sci. USA (1995) 92:2909–2913.
  • STEVENSON B, SCHWAN TG, ROSA PA: Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorkri. Infect. Immun. (1995) 63:4535–4539.
  • ANGUITA J, SAMANTA S, REVILLA B et al.: Borrelia burgdorlari gene expression in vivo and spirochete pathogenicity. Infect. Immun. (2000) 68:1222–1230.
  • SCHWAN TG, PIESMAN J: Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorkri, during the chain of infection in ticks and mice. j CBI]. 11/licrobial. (2000) 38:382–388.
  • CARROLL JA, CORDOVA RIVI, GARON CF: Identification of 11 pH-regulated genes in Borrelia burgdorkri localizing to linear plasmids. Infect. Immun. (2000) 68:6677–6684.
  • RAMAMOORTHY R, SCHOLL-MEEKER D: Borrelia burgdorlari proteins whose expression is similarly affected by culture temperature and pH. Infect. Immun. (2001) 69:2739–2742.
  • RAMAMOORTHY R, PHILIPP MT: Differential expression of Borrelia burgdorlari proteins during growth in vitro. Infect. Immun. (1998) 66:5119–5124.
  • YANG X, GOLDBERG MS, POPOVA TG et al.: Interdependence of environmental factors influencing reciprocal patterns of gene expression in virulent Borrelia bmgdorferi. Mal Microbial (2000) 37:1470–1479.
  • GROSS DM, HUBER BT: Cellular and molecular aspects of Lyme arthritis. Cell Life Sci. (2000) 57:1562–1569.
  • CHEN J, FIELD JA, GLICKSTEIN L et al.: Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorkri. Arthritis Rheum. (1999) 42:1813–1822.
  • CROKE CL, MUNSON EL, LOVRICH SD et al.: Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia bmgdorferi. Infect. 1171171L117. (2000) 68:658-663.
  • SIGAL LH, WILLIAMS S: A monoclonal antibody to Borrelia burgdorleri flagellin modifies neuroblastoma cell neuritogenesis in vitro: a possible role for autoimmunity in the neuropathy of Lyme disease. Infect. brunuri. (1997) 65:1722–1728.
  • JOHNSON RC, KODNER C, RUSSELL M: Active immunization of hamsters against experimental infection with Borrelia burgdorleri. Infect. Inimun. (1986) 54:897–898.
  • LOVRICH SD, CALLISTER SM, DUCHATEAU BK et al.: Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorleti to protect hamsters from infection. Infect. brunuri. (1995) 63:2113–2119.
  • PHILIPP MT, LOBET Y, BOHM RP Jr. et al.: The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine (1997) 15:1872–1887.
  • FOLEY DM, WANG YE WU XY et al.: Acquired resistance to Borrelia burgdorleri infection in the rabbit. Comparison between outer surface protein A vaccine-and infection-derived immunity. I Gun. Invest. (1997) 99:2030–2035.
  • PROBERT WS, LEFEBVRE RB: Protection of C3H/HeN mice from challenge with Borrelia burgdorleri through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen. Infect. Inimun. (1994) 62:1920–1926.
  • SCHAIBLE UE, KRAMER MD, EICHMANN K et al.: Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorleri prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc. Nati Acad. Li. USA (1990) 87:3768–3772.
  • COUGHLIN RT, FISH D, MATHER TN et al.: Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB and the saponin adjuvant Q521. J. Infect. Dis. (1995) 171:1049–1052.
  • CHANG YE APPEL MJ, JACOBSON RH et al.: Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorleri. Infect. hum= (1995) 63:3543–3549.
  • SIGAL LH, ZAHRADNIK JM, LAVIN P et al.: A vaccine consisting of recombinant Borrelia burgdorleri outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl. j Med. (1998) 339:216–222.
  • ••Analysis of a large scale human OspA vaccination trial.
  • STEERE AC, SIKAND VK, MEURICE F et al.: Vaccination against Lyme disease with recombinant Borrelia burgdorleri outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl. Med. (1998) 339:209–215.
  • ••Analysis of a large scale human OspAvaccination trial.
  • FIKRIG E, BARTHOLD SW, MARCANTONIO N et al.: Roles of OspA, OspB and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. hum= (1992) 60:657–661.
  • ZHONG W, GERN L, STEHLE T et al.: Resolution of experimental and tick-borne Borrelia burgdorleri infection in mice by passive, but not active immunization using recombinant OspC. Eur. (1999) 29:946–957.
  • HANSON MS, CASSATT DR, GUO BP et al.: Active and passive immunity against Borrelia burgdorleri decorin binding protein A (DbpA) protects against infection. Infect. hum= (1998) 66:2143–2153.
  • EXNER MM, WU X, BLANCO DR, MILLER JN, LOVETT MA: Protection elicited by native outer membrane protein 0ms66 (p66) against host-adapted Borrelia burgdorlert. conformational nature of bactericidal epitopes. Infect. brunun. (2000) 68:2647–2654.
  • NGUYEN TI LAM TT, BARTHOLD SW etal.: Partial destruction of Borrelia burgdorleri within ticks that engorged on OspE- or OspF-immunized mice. Infect. hum= (1994) 62:2079–2084.
  • FIKRIG E, FENG W, BARTHOLD SW, TELFORD SR, 3rd, FLAVELL RA: Arthropod- and host-specific Borrelia burgdorleribbk32 expression and the inhibition of spirochete transmission. brunurial. (2000) 164:5344–5351.
  • LABANDEIRA-REY M, BAKER EA, SKARE JT: VraA (BBIl 6) protein of Borrelia burgdorleri is a surface-exposed antigen with a repetitive motif that confers partial protection against experimental Lyme borreliosis. Infect. brunuri. (2001) 69:1409–1419.
  • BEY RF, LARSON ME, LOWERY DE et al.: Protection of C3H/Fle mice from experimental Borrelia burgdorleri infection by immunization with a 110-kilodalton fusion protein. Infect. hum= (1995) 63:3213–3217.
  • GERN L, RAIS 0, CAPIAU C et al.: Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorleri infection induced by Ixodes ricinus tick bites. Inimurial. Lett. (1994) 39:249–258.
  • FIKRIG E, TELFORD SR, 3rd, BARTHOLD SW et al.: elimination of Borrelia burgdorleri from vector ticks feeding on ospa-immunized mice. Proc. Natl. Acad. Sci. USA (1992) 89:5418–5421.
  • DE SILVA AM, TELFORD SR, 3RD, BRUNET LR, BARTHOLD SW, FIKRIG E: Borrelia burgdorkri OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. I Exp. Med. (1996) 183:271–275.
  • Lyme disease- United States, 1996. MMWR Morb. Mortal Wkiy Rep. (1997) 46:531–535.
  • JONSSON M, NOPPA L, BARBOUR AG, BERGSTROM S: Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins. Infect. brunuri. (1992) 60:1845–1853.
  • MATHIESEN DA, OLIVER JH, JR., KOLBERT CP et al.: Genetic heterogeneity of Borrelia burgdorleri in the United States. Infect. Dis. (1997) 175:98–107.
  • WILSKE B, BUSCH U, EIFFERT H etal.: Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorlerisensu lato from patients with neuroborreliosis in Germany. Med. Microbial. Inimurial. (Berl) (1996) 184:195–201.
  • MARCONI RT, KONKEL ME, GARON CF: Variability of osp genes and gene products among species of Lyme disease spirochetes. Infect. Inimun. (1993) 61:2611–2617.
  • BARBOUR AG, HEILAND RA, HOWE TR: Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. Infect. Dis. (1985) 152:478–484.
  • PROBERT WS, CRAWFORD M, CADIZ RB, LEFEBVRE RB: Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. I Infect. Dis. (1997) 175:400–405.
  • FIKRIG E, TELFORD SR, 3rd, WALLICH R etal.: Vaccination against Lyme disease caused by diverse Borrelia Expert Op/n. Biol. Ther. (2001) 1(5) burgdorleri. J Exp. Med. (1995) 181:215–221.
  • TELFORD SR, 3rd, FIKRIG E, BARTHOLD SW etal.: Protection against antigenically variable Borrelia burgdorkri conferred by recombinant vaccines. J Exp. Med. (1993) 178:755–758.
  • MASUZAWA T, KURITA T, YANAGIHARA Y: Negative finding in cross-protective activity of Japanese Borrelia isolates against infection with three species of Lyme disease Borrelia in outbred mice. MicrobioL InunurioL (1997) 41:733–736.
  • MAY, WETS JJ: Borrelia burgdorkri outersurface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Inunuri. (1993) 61:3843–3853.
  • BURKOT TR, PIESMAN J, WIRTZ RA: Quantitation of the Borrelia burgdorkri outer surface protein A in Ixodes scapularis: fluctuations during the tick life cycle, doubling times and loss while feeding. J Infect. Dis. (1994) 170:883–889.
  • FINGERLE V, LIEGL G, MUNDERLOH U, WILSKE B: Expression of outer surface proteins A and C of Borrelia burgdorkii in Ixodes ricinus ticks removed from humans. Med. ll/licrobioL IntinurioL (Ben) (1998) 187:121–126.
  • MARGOLIS N, ROSA PA: Regulation of expression of major outer surface proteins in Borrelia burgdorkri Infect. Inunuri. (1993) 61:2207–2210.
  • WILSKE B, PREAC-PMURSIC V, SCHIERZ G et al.: Antigenic variability of Borrelia burgdorkri. Ann. NY Acad. Sci. (1988) 539.
  • FIKRIG E, TAO H, KANTOR FS, BARTHOLD SW, FLAVELL RA: Evasion of protective immunity by Borrelia burgdorkriby truncation of outer surface protein B. Proc. Natl. Acad. Sci. USA (1993) 90:4092–4096.
  • PROBERT WS, CRAWFORD M, LEFEBVRE RB: Antibodies to OspB prevent infection of C3H mice challenged with Borrelia burgdorkri isolates expressing truncated OspB antigens. Vaccine (1997) 15:15–19.
  • SADZIENE A, WILSKE B, FERDOWS MS, BARBOUR AG: The cryptic ospC gene of Borrelia burgdorkri B31 is located on a circular plasmid. Infect. Linn= (1993) 61:2192–2195.
  • FUNG BP, MCHUGH GL, LEONG JM, STEERE AC: Humoral immune response to outer surface protein C of Borrelia burgdorkri in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Infect. Inunuri. (1994) 62:3213–3221.
  • THEISEN M, FREDERIKSEN B, LEBECH AM, VUUST J, HANSEN K: Polymorphism in ospC gene of Borrelia burgdorkri and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen. J Clin. ll/licrobioL (1993) 31:2570–2576.
  • JAURIS-HEIPKE S, LIEGL G, PREAC-MURSIC V et al.: Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorkri sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC. Microbial. (1995) 33:1860–1866.
  • THEISEN M, BORRE M, MATHIESEN MJ et al.: Evolution of the Borrelia burgdorkri outer surface protein OspC. Bacteria (1995) 177:3036–3044.
  • JAURIS-HEIPKE S, FUCHS R, MOTZ M etal.: Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdolferi. Med MicrobioL 1171171L11701. (Ben) (1993) 182:37–50.
  • WANG IN, DYKHUIZEN DE, QIU W et al.: Genetic diversity of ospC in a local population of Borrelia burgdorkri sensu strict°. Genetics (1999) 151:15–30.
  • PREAC-MURSIC V, WILSKE B, PATSOURIS E et al.: Active immunization with pC protein of Borrelia burgdorkri protects gerbils against B. burgdorkri infection. Infection (1992) 20:342–349.
  • GILMORE RD, JR., KAPPEL KJ, DOLAN MC, BURKOT TR, JOHNSON BJ: Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorkri challenge: evidence for a conformational protective epitope in OspC. Infect. Immuri. (1996) 64:2234–2239.
  • ZHONG W, STEHLE T, MUSETEANU C etal.: Therapeutic passive vaccination against chronic Lyme disease in mice. Proc. Natl. Acad. Sci. USA (1997) 94:12533–12538.
  • MBOW ML, GILMORE RD, Jr., TITUS RG: An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorkri B31. Infect. Inunuri. (1999) 67:5470–5472.
  • IKUSHIMA M, MATSUI K, YAMADA E KAWAHASHI S, NISHIKAWA SK: Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorkri predicts protective borreliacidal antibodies. FEMS IntinurioL Med. Microbial. (2000) 29:15–21.
  • GUO BP, NORRIS SJ, ROSENBERG LC, HOOK M: Adherence of Borrelia burgdorkri to the proteoglycan decorin. Infect. Inunuri. (1995) 63:3467–3472.
  • GUO BP, BROWN EL, DORWARD DW, ROSENBERG LC, HOOK M: Decorin-binding adhesins from Borrelia burgdorkri MoL MicrobioL (1998) 30:711–723.
  • ROBERTS WC, MULLIKIN BA, LATHIGRA R, HANSON MS: Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorkrisensu lato. Infect. Inunuri. (1998) 66:5275–5285.
  • FENG S, HODZIC E, STEVENSON B, BARTHOLD SW: Humoral immunity to Borrelia burgdorkri N40 decorin binding proteins during infection of laboratory mice. Infect. Intinuri. (1998) 66:2827–2835.
  • HAGMAN KE, LAHDENNE P, POPOVA TG et al.: Decorin-binding protein of Borrelia burgdorkri is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect. Inunuri. (1998) 66:2674–2683.
  • HANSON MS, PATEL NK, CASSATT DR, ULBRANDT ND: Evidence for vaccine synergy between Borrelia burgdorkri decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis. Infect. Linn= (2000) 68:6457–6460.
  • •Demonstration of synergy and enhanced protective immunity using two immunogens.
  • BUNIKIS J, NOPPA L, BERGSTROM S: Molecular analysis of a 66-kDa protein associated with the outer membrane of Lyme disease Borrelia. FEMS NlicrobioL Lett. (1995) 131:139–145.
  • BUNIKIS J, NOPPA L, OSTBERG Y, BARBOUR AG, BERGSTROM S: Surface exposure and species specificity of an immunoreactive domain of a 66-kilodalton outer membrane protein (P66) of the Borrelia spp. that cause Lyme disease. Infect. Immuri. (1996) 64:5111–5116.
  • BUNIKIS J, LUKE CJ, BUNIKIENE E, BERGSTROM S, BARBOUR AG: A surface-exposed region of a novel outer membrane protein (P66) of Borrelia spp. is variable in size and sequence. J. Bacteria (1998) 180:1618–1623.
  • PROBERT WS, ALLSUP KM, LEFEBVRE RB: Identification and characterization of a surface-exposed, 66-kilodalton protein from Borrelia burgdorferi Infect. kronur]. (1995) 63:1933–1939.
  • SKARE JT, MIRZABEKOV TA, SHANG ES et al: The 0ms66 (p66) protein is a Borrelia burgdorkriporin. Infect. bronurr. (1997) 65:3654–3661.
  • COBURN J, CHEGE W, MAGOUN L, BODARY SC, LEONG JM: Characterization of a candidate Borrelia burgdorkribeta3-chain integrin ligand identified using a phage display library. Mal. Microbial (1999) 34:926–940.
  • DEFOE G, COBURN J: Delineation of Borrelia burgdorkrip66 sequences required for integrin alpha(llb)beta(3) recognition. Infect. kronur]. (2001) 69:3455–3459.
  • NTCHOBO H, ROTHERMEL H, CHEGE W, STEERE AC, COBURN J: Recognition of multiple antibody epitopes throughout Borrelia burgdorkri p66, a candidate adhesin, in patients with early or late manifestations of Lyme disease. Infect. brim= (2001) 69:1953–1956.
  • BUNIKIS J, BARBOUR AG: Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorkri is hindered by Osp lipoproteins. Infect. kronur]. (1999) 67:2874–2883.
  • LAM TT, NGUYEN TI MONTGOMERY RR et al.: Outer surface proteins E and F of Borrelia burgdorkri, the agent of Lyme disease. Infect. Inunurr. (1994) 62:290–298.
  • SUNG SY, LAVOIE CP, CARLYON JA, MARCONI RT: Genetic divergence and evolutionary instability in ospE-related members of the upstream homology box gene family in Borrelia burgdorkrisensu lato complex isolates. Infect. Inunurr. (1998) 66:4656–4668.
  • PROBERT WS, KIM JH, HOOK M, JOHNSON BJ: Mapping the ligand-binding region of Borrelia burgdorkri fibronectin-binding protein BBK32. Infect. brim= (2001) 69:4129–4133.
  • PROBERT WS, JOHNSON BJ: Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorkri isolate B31. Mal Microbial (1998) 30:1003–1015.
  • FIKRIG E, FENG W, AVERSA J, SCHOEN RT, FLAVELL RA: Differential expression of Borrelia burgdorkri genes during erythema migrans and Lyme arthritis.j Infect. Dis. (1998) 178:1198–1201.
  • WILL G, JAURIS-HEIPKE S, SCHWAB E etal.: Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorkri sensu stricto and Borrelia afzelli strains but reveals major subgroups within the Borrelia gannii species. Med. Nlicrobial Irronurral (Ber) (1995) 184:73–80.
  • SKARE JT, FOLEY DM, HERNANDEZ SR et al.: Cloning and molecular characterization of plasmid-encoded antigens of Borrelia burgdorkri. Infect. brim= (1999) 67:4407–4417.
  • LUFT BJ, GOREVIC PD, JIANG W, MUNOZ E DATTWYLER RJ: Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorkri Inunurral (1991) 146:2776–2782.
  • ANZOLA J, LUFT BJ, GORGONE Get al.: Borrelia burgdorkriHSP70 homolog: characterization of an immunoreactive stress protein. Infect. Inunurr. (1992) 60:3704–3713.
  • CAPUTA A, MURTAUGH M, BEY, RF, LOKEN K: 100-kilodalton recomninant protein which is immunoreactive with sera from humans, dogs and horses with Lyme borreliosis.j. Gun. Microbial. (1991) 29:2418–2423.
  • LIVEY I, GIBBS C, SCHUSTER R, DORNER F: Evidence for lateral transfer and recombination in OspC variation in Lyme disease Borrelia. Mal Nlicrobial (1995) 18:257–269.
  • RAS N, POSTIC D, FORETZ M, BARANTON G: Borrelia burgdorkrisensu strict°, a bacterial species 'Made in the USA?' Int. j Syst. Bacterial (1997) 47:1112–1117.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.